We are exploring how Dupilumab may improve nasal barrier function in patients with Chronic Rhinosinusitis with nasal polyps. This study compares the effects of treatment on nasal cells from patients and healthy controls.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a long-term inflammation of the sinuses that leads to the growth of polyps in the nasal passages, causing symptoms like nasal congestion, loss of smell, and facial pain.
Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) is a condition characterized by long-term inflammation of the sinuses without the presence of polyps, leading to symptoms such as nasal blockage, facial pressure, and reduced sense of smell.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.